Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer Conversion to Resection and Long-term Outcomes

DAngelica Michael I.; Correa-Gallego Camilo; Paty Philip B.; Cercek Andrea; Gewirtz Alexandra N.; Chou Joanne F.; Capanu Marinella; Kingham T. Peter; Fong Yuman; DeMatteo Ronald P.; Allen Peter J.; Jarnagin William R.; Kemeny Nancy

首页> 外文期刊>Annals of Surgery >Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer Conversion to Resection and Long-term Outcomes

【24h】

Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer Conversion to Resection and Long-term Outcomes

机译：从结肠直肠癌转换为切除和长期结局的无法切除的肝转移患者的肝动脉灌注和全身化学治疗的II期试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: Evaluate conversion rate of patients with unresectable colorectal-liver metastasis to complete resection with hepatic-arterial infusion plus systemic chemotherapy including bevacizumab (Bev).

机译：目的：评估无法切除的结直肠肝转移患者的肝动脉输注加上全身化疗（包括贝伐单抗（Bev））的完全切除率。

著录项

来源
《Annals of Surgery》 |2015年第2期|共8页
作者
DAngelica Michael I.; Correa-Gallego Camilo; Paty Philip B.; Cercek Andrea; Gewirtz Alexandra N.; Chou Joanne F.; Capanu Marinella; Kingham T. Peter; Fong Yuman; DeMatteo Ronald P.; Allen Peter J.; Jarnagin William R.; Kemeny Nancy;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科学;
关键词
bevacizumab; colorectal liver metastasis; fluxoridine; hepatectomy; intrahepatic infusional chemotherapy;

机译：贝伐单抗;大肠肝转移;氟哌啶;肝切除术;肝内灌注化疗;

相似文献

外文文献
中文文献
专利

1. Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer Conversion to Resection and Long-term Outcomes [J] . DAngelica Michael I., Correa-Gallego Camilo, Paty Philip B., Annals of Surgery . 2015,第2期

机译：从结肠直肠癌转换为切除和长期结局的无法切除的肝转移患者的肝动脉灌注和全身化学治疗的II期试验
2. Conversion to Complete Resection and/or Ablation Using Hepatic Artery Infusional Chemotherapy in Patients with Unresectable Liver Metastases from Colorectal Cancer: A Decade of Experience at a Single Institution [J] . Ammori John B., Kemeny Nancy E., Fong Yuman, Annals of surgical oncology . 2013,第9期

机译：在无法切除的结直肠癌肝转移患者中，采用肝动脉灌注化疗转换为完全切除和/或消融术：在单一机构中的十年经验
3. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential [J] . Pak Linda M., Kemeny Nancy E., Capanu Marinela, Journal of Surgical Oncology . 2018,第4期

机译：治疗肝动脉输注组合的前瞻性期II试验和全身化疗进行不可切入结直肠肝转移：长期成果和疗效
4. Clinical Trial of Liposome-Adriamycin (Lipo-ADR) via the Portal Vein and Hepatic Artery for Prophylaxis and Treatment after Hepatic Resection on Liver Metastasis in Advanced Gastric Cancer [C] . I. Mizuno, T. Yotsuyanagi, M. Ishida, International Gastric Cancer Congress . 2009

机译：脂质体 - 亚霉素（Lipo-ADR）通过门静脉和肝动脉进行预防和治疗治疗晚期胃癌肝转移后的临床试验
5. Transcriptional and transductional adenovirus targeting therapy for hepatic colorectal cancer metastases. [D] . Li, Hua-Jung. 2007

机译：转录和转导腺病毒靶向治疗肝大肠癌转移。
6. Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: Conversion to resection and long-term outcomes [O] . Michael I. D’Angelica, Camilo Correa-Gallego, Philip B. Paty, -1

机译：肝动脉输注和全身化疗对结直肠癌无法切除的肝转移患者的II期试验：转换为切除术和长期预后
7. Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic Metastases From Colorectal Cancer [O] . Nancy E. Kemeny, William R. Jarnagin, Marinela Capanu, 2011

机译：辅助肝动脉输注的随机期II试验和患者患者中患者的肝脏肝动脉输注和系统化疗，从结肠直肠癌切除肝脏转移患者

Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer Conversion to Resection and Long-term Outcomes

摘要

著录项

相似文献

相关主题

期刊订阅